HCM
CALA

Howland Capital Management’s Calithera Biosciences, Inc CALA Stock Holding History

Howland Capital Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-600
Closed -$178K – 229
2017
Q2 		$178K Hold
600
– – 0.02% 218
2017
Q1 		$139K Hold
600
– – 0.01% 217
2016
Q4 		$39K Hold
600
– – ﹤0.01% 209
2016
Q3 		$39K Hold
600
– – ﹤0.01% 205
2016
Q2 		$45K Hold
600
– – ﹤0.01% 203
2016
Q1 		$68K Sell
600
-73
-11% -$8.27K 0.01% 197
2015
Q4 		$103K Hold
673
– – 0.01% 199
2015
Q3 		$73K Hold
673
– – 0.01% 188
2015
Q2 		$96K Buy
+673
New +$156K 0.01% 194

Other funds holding CALA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Howland Capital Management's CALA Position: Q3 2017 in Review

Howland Capital Management sold out of Calithera Biosciences, Inc (CALA) in Q3 2017, closing a stake of 600 shares — an estimated $178K sold.

Howland Capital Management first reported a position in CALA in Q2 2015 and held it in 9 quarters. The position peaked at $178K in Q2 2017. 91 funds tracked by Wall St. Rank hold CALA as of Q3 2017.

  • Howland Capital Management reported no remaining Calithera Biosciences, Inc position as of Q3 2017 after selling out during the quarter.
  • Howland Capital Management sold 600 Calithera Biosciences, Inc shares in Q3 2017, an estimated $178K.
  • Howland Capital Management first reported a position in Calithera Biosciences, Inc in Q2 2015 and held it in 9 quarters.
  • Howland Capital Management's Calithera Biosciences, Inc position peaked at $178K in Q2 2017.
  • 91 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2017.

Based on Howland Capital Management's 13F filing for Q3 2017, filed 30 Oct 2017.